✦ LIBER ✦

Prevention of intrahepatic recurrence by adjuvant 131iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis

✍ Scribed by M. Tabone; L. Vigano'; A. Ferrero; R. Pellerito; P. Carbonatto; L. Capussotti

Book ID: 118435835
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 283 KB
Volume: 33
Category: Article
ISSN: 0748-7983
DOI: 10.1016/j.ejso.2006.10.039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant iodine-131-labeled lipiodol for

Adjuvant iodine-131-labeled lipiodol for prevention of intrahepatic recurrence of hepatocellular carcinoma: Which is the best treatment schedule?

✍ Marco Tabone; Luca Vigano; Cristiana Laudi; Alessandro Ferrero; Riccardo Pelleri 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

Prevention of hepatocellular carcinoma r

Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis

✍ Vincenzo Mazzaferro; Raffaele Romito; Marcello Schiavo; Luigi Mariani; Tiziana C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 563 KB

Tumor recurrence after resection of hepatocellular carcinoma (HCC) can occur early (<2 years) or late (>2 years) as metastases or de novo tumors. Interferon (IFN) has the potential for chemoprevention against hepatitis C virus (HCV)-related cirrhosis. A predetermined group of 150 HCV RNA-positive pa

94 Prospective randomised trial on IFN-t

94 Prospective randomised trial on IFN-therapy for the secondary prevention of HCC recurrence after curative resection in HCV related cirrhosis. Preliminary report

✍ V. Mazzaferro; R. Romito; M. Colombo; L. Capussotti; R. Polastri; R. Pellicci; F 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 64 KB